 |
 |
We finished two trials in 2009.
We currently have two active clinical trials. One study is sponsored by Pfizer and invloves the use of their antiinflamatory drug, Celebrex, as compared to two other
over the counter medications, naproxen sodium and ibuprophen. The goal of the study is to prove the effectiveness as well as the safety of Celebrex. Specifically,
Pfizer is looking to show that those with concommitant cardio vascular health issues such as high blood pressure, high cholesterol, a history of a heart attack or stroke,
do not have a higher rate of side effects while on Celebrex than those on the other antiinflammatories. The study follows patients over the course of three years.
Particiapants are provided with medication at no cost and also receive blood work and an EKG at no charge to them.
Additionally, the sponsor pays patients in the study for their time and travel to participate in the trial.
We are also one of only 6 sites in the U.S. chosen to participate in a surgical study with Zimmer utelizing a new cartilage product. The study involves the use of
allograft (cadaveric) cartilage plugs to fill in arthritic lesions in the knee. Patients are then followed for 5 years after the surgery. The product is FDA approved,
but only available to those physicians who have been chosen to be part of the trial. It is a very exciting opportunity to provide our patients with the latest advances
in minimally invasive procedures to address arthritis.
|
|
 |
|
|
|
To Learn More About Us
Click On The Video Above
Click to View Our Foundation Brochure
Kevin Plancher, MD, Chairman of the Board
Janine D. Bahar, Executive Director
Duane Hill
George Kollitides II
Albert Nickel
Robert Plancher
Jonathan Scott
Kenneth M. Wisdom
Mary Ellen Yacura
 |
|
|
|
|
